The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis
Open accessAbstract
Nonalcoholic steatohepatitis (NASH) is a leading cause of cirrhosis. Recently, we showed that NASH-related cirrhosis is associated with Hedgehog (Hh) pathway activation. The gene encoding osteopontin (OPN), a profibrogenic extracellular matrix protein and cytokine, is a direct transcriptional target of the Hh pathway. Thus, we hypothesize that Hh signaling induces OPN to promote liver fibrosis in NASH. Hepatic OPN expression and liver fibrosis were analyzed in wild-type (WT) mice, Patched-deficient (Ptc+/−) (overly active Hh signaling) mice, and OPN-deficient mice before and after feeding methionine and choline–deficient (MCD) diets to induce NASH-related fibrosis. Hepatic OPN was also quantified in human NASH and nondiseased livers. Hh signaling was manipulated in cultured liver cells to assess direct effects on OPN expression, and hepatic stellate cells (HSCs) were cultured in medium with different OPN activities to determine effects on HSC phenotype. When fed MCD diets, Ptc+/− mice expressed more OPN and developed worse liver fibrosis ( P < 0.05) than WT mice, whereas OPN-deficient mice exhibited reduced fibrosis ( P < 0.05). In NASH patients, OPN was significantly up-regulated and correlated with Hh pathway activity and fibrosis stage. During NASH, ductular cells strongly expressed OPN. In cultured HSCs, SAG (an Hh agonist) up-regulated, whereas cyclopamine (an Hh antagonist) repressed OPN expression ( P < 0.005). Cholangiocyte-derived OPN and recombinant OPN promoted fibrogenic responses in HSCs ( P < 0.05); neutralizing OPN with RNA aptamers attenuated this ( P < 0.05). Conclusion: OPN is Hh-regulated and directly promotes profibrogenic responses. OPN induction correlates with Hh pathway activity and fibrosis stage. Therefore, OPN inhibition may be beneficial in NASH (Hepatology 2011)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Like hepatocytes, cholangiocytes can undergo lipoapoptosis and senescence in the presence of increased saturated fatty acids, which may provoke release of damage-associated molecular patterns, senescence-associated secretory patterns (such as chemokine ligand 2 (CCL2)), and SPP1, which activate HSCs to generate fibrosis (37-40).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [38]
In the citing paper
“SPP1, a downstream target of hedgehog signaling, is induced in myofibroblasts in MASH, and its antagonism reduces fibrosis in the MCD mouse model (38, 159).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., & Cantor, H. (2000) · Science · doi:10.1126/science.287.5454.860 · Cited by 1,125
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
Chabas, D., Baranzini, S. E., Mitchell, D., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M., Pedotti, R., et al. (2001) · Science · doi:10.1126/science.1062960 · Cited by 829
Osteopontin: role in cell signaling and cancer progression
Rangaswami, H., Bulbule, A., & Kundu, G. C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.12.005 · Cited by 738
THE INFLUENCE OF THE PROINFLAMMATORY CYTOKINE, OSTEOPONTIN, ON AUTOIMMUNE DEMYELINATING DISEASE
Chabas, D., Baranzini, S. E., Mitchell, D. J., Bernard, C. C. A., Rittling, S. R., Denhardt, D. T., Sobel, R. A., Lock, C., Karpuj, M. V., Pedotti, R., et al. (2002) · International Conference on Osteopontin and SIBLING Proteins · doi:10.1100/tsw.2002.326 · Cited by 729
Wieckowska, A., Zein, N. N., Yerian, L. M., López, R., McCullough, A. J., & Feldstein, A. E. (2006) · Hepatology · doi:10.1002/hep.21223 · Cited by 675
Kupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand and Cytokine Expression
Canbay, A. E., Feldstein, A. E., Higuchi, H., Werneburg, N., Grambihler, A., Bronk, S. F., & Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50472 · Cited by 470
Omenetti, A., Porrello, A., Jung, Y., Yang, L., Popov, Y. V., Choi, S. S., Witek, R. P., Alpini, G. D., Venter, J., VanDongen, H. M. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35875 · Cited by 346
Self-citationAnimal models of NASH: Getting both pathology and metabolic context right
Larter, C. Z., & Yeh, M. M. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05543.x · Cited by 340
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Immune cell-mediated features of non-alcoholic steatohepatitis
Huby, T., & Gautier, E. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00639-3 · Cited by 573
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Wang, X., Zheng, Z., Caviglia, J. M., Corey, K. E., Herfel, T. M., Cai, B., Masia, R., Chung, R. T., Lefkowitch, J. H., Schwabe, R. F., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.016 · Cited by 413
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
Peverill, W., Powell, L. W., & Skoien, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058591 · Cited by 387
Moylan, C. A., Pang, H., Dellinger, A. E., Suzuki, A., Garrett, M. E., Guy, C. D., Murphy, S. K., Ashley‐Koch, A. E., Choi, S. S., Michelotti, G. A., et al. (2013) · Hepatology · doi:10.1002/hep.26661 · Cited by 319
Self-citationPathogenesis of biliary atresia: defining biology to understand clinical phenotypes
Asai, A., Miethke, A. G., & Bezerra, J. A. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.74 · Cited by 282
Hedgehog signaling in the liver
Omenetti, A., Choi, S. S., Michelotti, G. A., & Diehl, A. M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.003 · Cited by 285
Self-citationAdaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH
Sutti, S., Jindal, A., Locatelli, I., Vacchiano, M., Gigliotti, L., Bozzola, C., & Albano, E. (2014) · Hepatology · doi:10.1002/hep.26749 · Cited by 270
NKT-Associated Hedgehog and Osteopontin Drive Fibrogenesis in Non-Alcoholic Fatty Liver Disease
Syn, W.-K., Agboola, K. M., Swiderska, M., Michelotti, G. A., Liaskou, E., Pang, H., Xie, G., Philips, G., Chan, I. S., Karaca, G. F., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301857 · Cited by 266
Self-citationUrtasun, R., Lopategi, A., George, J., Leung, T. M., Lu, Y., Wang, X., Ge, X., Fiel, M. I., & Nieto, N. (2011) · Hepatology · doi:10.1002/hep.24701 · Cited by 257
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Zhu, C., Kim, K., Wang, X., Bartolome, A., Salomao, M., Dongiovanni, P., Meroni, M., Graham, M. J., Yates, K. P., Diehl, A. M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0344 · Cited by 250
Self-citationPathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Lee, K., Wu, P.-S., & Lin, H. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0237 · Cited by 269
Principles of Liver Regeneration and Growth Homeostasis
Michalopoulos, G. K. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120014 · Cited by 278
Weber, C., Kothari, A. N., Wai, P. Y., Li, N. Y., Driver, J., Zapf, M. A. C., Franzen, C. A., Gupta, G. N., Osipo, C., Zlobin, A., et al. (2014) · Oncogene · doi:10.1038/onc.2014.410 · Cited by 235
Self-citationYilmaz, Y. N. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12046 · Cited by 217
Tillman, E. J., & Rolph, T. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.601290 · Cited by 214
Molecular Pathogenesis of NASH
Caligiuri, A., Gentilini, A., & Marra, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091575 · Cited by 219
Hedgehog-Gli Pathway Activation during Kidney Fibrosis
Fabian, S. L., Penchev, R., St‐Jacques, B., Rao, A. N., Sipilä, P., West, K. A., McMahon, A. P., & Humphreys, B. D. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.12.039 · Cited by 206
Non-alcoholic fatty liver disease: What the clinician needs to know
Machado, M. V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12956 · Cited by 215
Extracellular Matrix and Liver Disease
Arriazu, E., de Galarreta, M. R., Cubero, F. J., Varela‐Rey, M., de Obanos, M. P. P., Leung, T. M., Lopategi, A., Benedicto, A., Abraham‐Enachescu, I., & Nieto, N. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5697 · Cited by 206
Pathogenesis of alcohol‐induced liver disease: Classical concepts and recent advances
Seth, D., Haber, P. S., Syn, W., Diehl, A. M., & Day, C. P. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06756.x · Cited by 166
Self-citationPhilips, G., Chan, I. S., Swiderska, M., Schroder, V. T., Guy, C. D., Karaca, G., Moylan, C. A., Venkatraman, T. N., Feuerlein, S., Syn, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023943 · Cited by 164
Self-citationKumar, V., Xin, X., Ma, J., Tan, C., Osna, N. A., & Mahato, R. I. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113888 · Cited by 165
Osteopontin -- a promising biomarker for cancer therapy
Wei, R., Wong, J. P. C., & Kwok, H. F. (2017) · Journal of Cancer · doi:10.7150/jca.20480 · Cited by 159
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases
Clemente, N., Raineri, D., Cappellano, G., Boggio, E., Favero, F., Soluri, M. F., Dianzani, C., Comi, C., Dianzani, U., & Chiocchetti, A. (2016) · Journal of Immunological Research · doi:10.1155/2016/7675437 · Cited by 156
Hedgehog signalling in liver pathophysiology
Machado, M. V., & Diehl, A. M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.017 · Cited by 155
Self-citationImmunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
McQuitty, C. E., Williams, R., Chokshi, S., & Urbani, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574276 · Cited by 146
Reid, D. T., Reyes, J. L., McDonald, B., Vo, T., Reimer, R. A., & Eksteen, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159524 · Cited by 150
Machado, M. V., Michelotti, G. A., Pereira, T. A., Xie, G., Premont, R., Cortez-Pinto, H., & Diehl, A. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.05.031 · Cited by 135
Self-citationHedgehog signalling regulates liver sinusoidal endothelial cell capillarisation
Xie, G., Choi, S. S., Syn, W., Michelotti, G. A., Swiderska, M., Karaca, G., Chan, I. S., Chen, Y., & Diehl, A. M. (2012) · Gut · doi:10.1136/gutjnl-2011-301494 · Cited by 135
Self-citationNati, M., Haddad, D., Birkenfeld, A. L., Koch, C. A., Chavakis, T., & Chatzigeorgiou, A. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9339-2 · Cited by 138
Kim, K. H., Kim, S., Han, D. H., Jo, Y. S., Lee, Y., & Lee, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25098-0 · Cited by 130
Qian, J., LeSavage, B. L., Hubka, K. M., Ma, C., Natarajan, S., Eggold, J. T., Xiao, Y., Fuh, K. C., Krishnan, V., Enejder, A. M. K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146186 · Cited by 132
CD44 is a key player in non-alcoholic steatohepatitis
Patouraux, S., Rousseau, D., Bonnafous, S., Lebeaupin, C., Luci, C., Canivet, C. M., Schneck, A.-S., Bertola, A., Saint‐Paul, M., Iannelli, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.003 · Cited by 139
Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis
Hou, W., & Syn, W. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00150 · Cited by 121
Self-citationOsteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice
Lazaro, R. G., Wu, R. P., Lee, S., Zhu, N., Chen, C., French, S. W., Xu, J., Machida, K., & Tsukamoto, H. (2014) · Hepatology · doi:10.1002/hep.27383 · Cited by 120
Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy
Swiderska-Syn, M., Syn, W. K., Xie, G., Krüger, L., Machado, M. V., Karaca, G., Michelotti, G. A., Choi, S. S., Premont, R. T., & Diehl, A. M. (2014) · Gut · doi:10.1136/gutjnl-2013-305962 · Cited by 115
Self-citationOsteopontin—A Master Regulator of Epithelial-Mesenchymal Transition
Kothari, A. N., Arffa, M., Chang, V. A., Blackwell, R. H., Syn, W., Zhang, J., Mi, Z., & Kuo, P. C. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040039 · Cited by 117
Self-citationSchulien, I., Hockenjos, B., Schmitt-Graeff, A., Perdekamp, M. G., Follo, M., Thimme, R., & Hasselblatt, P. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0239-8 · Cited by 111
Role of Osteopontin in Liver Diseases
Wen, Y., Jeong, S., Xia, Q., & Kong, X. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.16445 · Cited by 109
Osteopontin induces ductular reaction contributing to liver fibrosis
Wang, X., Lopategi, A., Ge, X., Lu, Y., Kitamura, N., Urtasun, R., Leung, T.-M., Fiel, M. I., & Nieto, N. (2014) · Gut · doi:10.1136/gutjnl-2013-306373 · Cited by 108
McGettigan, B. M., McMahan, R. H., Orlicky, D. J., Burchill, M. A., Danhorn, T., Francis, P., Cheng, L. L., Golden‐Mason, L., Jakubzick, C., & Rosen, H. R. (2018) · Hepatology · doi:10.1002/hep.30401 · Cited by 107
Host Regulators of Liver Fibrosis During Human Schistosomiasis
Kamdem, S. D., Moyou‐Somo, R., Brombacher, F., & Nono, J. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02781 · Cited by 108
Kiefer, F. W., Neschen, S., Pfau, B., Legerer, B., Neuhofer, A., Kahle, M., Hrabé de Angelis, M., Schlederer, M., Mair, M., Kenner, L., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2170-0 · Cited by 104
Xie, R., & Liu, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.857110 · Cited by 98
Ismail, M. H., & Pinzani, M. (2009) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.45072 · Cited by 100
Innate Immunity and Pathogenesis of Biliary Atresia
Ortiz‐Perez, A., Donnelly, B., Temple, H., Tiao, G. M., Bansal, R., & Mohanty, S. K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00329 · Cited by 102
Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice
Coombes, J. D., Swiderska‐Syn, M., Dollé, L., Reid, D. T., Eksteen, B., Claridge, L. C., Briones-Orta, M. A., Shetty, S., Oo, Y. H., Riva, A., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306484 · Cited by 97
Self-citationHuman and experimental evidence supporting a role for osteopontin in alcoholic hepatitis
Morales‐Ibanez, O., Domínguez, M., Ki, S. H., Marcos, M., Chaves, F. J., Nguyen-Khac, É., Houchi, H., Affò, S., Sancho‐Bru, P., Altamirano, J., et al. (2013) · Hepatology · doi:10.1002/hep.26521 · Cited by 97
Pritchett, J. P., Harvey, E., Athwal, V. S., Berry, A. A., Rowe, C., Oakley, F., Moles, A., Mann, D. A., Bobola, N., Sharrocks, A. D., et al. (2012) · Hepatology · doi:10.1002/hep.25758 · Cited by 97
Glass, O., Henao, R., Patel, K., Guy, C. D., Gruss, H. J., Syn, W., Moylan, C. A., Streilein, R. D., Hall, R. P., Diehl, A. M., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1237 · Cited by 95
Self-citationMaricic, I., Sheng, H., Marrero, I., Seki, E., Kisseleva, T., Chaturvedi, S., Molle, N., Mathews, S., Gao, B., & Kumar, V. (2014) · Hepatology · doi:10.1002/hep.27632 · Cited by 94
Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver
Musso, G., Paschetta, E., Gambino, R., Cassader, M., & Molinaro, F. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.006 · Cited by 98
Implication of the Hedgehog pathway in hepatocellular carcinoma
Corte, C. M. D., Viscardi, G., Papaccio, F., Esposito, G., Martini, G., Ciardiello, D., Martinelli, E., Ciardiello, F., & Morgillo, F. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i24.4330 · Cited by 91
Osteopontin: Versatile modulator of liver diseases
Nagoshi, S. (2013) · Hepatology Research · doi:10.1111/hepr.12166 · Cited by 87
Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis
Hirsova, P., Ibrahim, S. H., Bronk, S. F., Yagita∥, H., & Gores, G. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070599 · Cited by 86
Kwon, H., Song, K., Han, C. L., Chen, W., Wang, Y., Dash, S., Lim, K., & Wu, T. (2015) · Hepatology · doi:10.1002/hep.28289 · Cited by 86
Patouraux, S., Bonnafous, S., Voican, C. S., Anty, R., Saint‐Paul, M., Rosenthal‐Allieri, M. A., Agostini, H., Njiké‐Nakseu, M., Barri‐Ova, N., Naveau, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035612 · Cited by 88
An Overview of Hedgehog Signaling in Fibrosis
Hu, L., Lin, X., Lu, H., Chen, B., & Bai, Y. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095141 · Cited by 85
Matricellular Protein Periostin Contributes to Hepatic Inflammation and Fibrosis
Huang, Y., Liu, W., Xiao, H., Maitikabili, A., Lin, Q., Wu, T., Huang, Z., Liu, F., Luo, Q., & Ouyang, G. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.11.002 · Cited by 88
Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?
Targher, G., Lonardo, A., & Rossini, M. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0315-6 · Cited by 83
Yilmaz, Y. N. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05196.x · Cited by 81
Hedgehog signaling in cholangiocytes
Omenetti, A., & Diehl, A. M. (2011) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834550b4 · Cited by 77
Self-citationCao, L., Fan, X., Jing, W., Liang, Y., Chen, R., Liu, Y., Zhu, M., Jia, R., Wang, H., Zhang, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3113 · Cited by 74
Hedgehog Signaling: Implications in Cancers and Viral Infections
Iriana, S., Asha, K., Repak, M., & Sharma-Walia, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031042 · Cited by 74
Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity
Guy, C. D., Suzuki, A., Abdelmalek, M. F., Burchette, J. L., Diehl, A. M., & CRN, F. T. N. (2015) · Hepatology · doi:10.1002/hep.27235 · Cited by 72
Self-citationLocatelli, I., Sutti, S., Vacchiano, M., Bozzola, C., & Albano, E. (2012) · Clinical Science · doi:10.1042/cs20120289 · Cited by 68
Seth, R. K., Kumar, A., Das, S., Kadiiska, M. B., Michelotti, G. A., Diehl, A. M., & Chatterjee, S. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft104 · Cited by 69
Self-citationOsteopontin – A potential biomarker of advanced liver disease
Brůha, R., Vı́tek, L., & Smid, V. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.01.001 · Cited by 66
Ding, J., Li, H., Zhang, L., Zhou, Y., & Wu, J. H. (2021) · Cells · doi:10.3390/cells10010123 · Cited by 66
A hedgehog survival pathway in ‘undead’ lipotoxic hepatocytes
Kakisaka, K., Cazanave, S. C., Werneburg, N. W., Razumilava, N., Mertens, J. C., Bronk, S. F., & Gores, G. J. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.011 · Cited by 65
Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
Vonghia, L., Michielsen, P. P., & Francque, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019867 · Cited by 68
Peripheral signalling involved in energy homeostasis control
Lancha, A., Frühbeck, G., & Gómez‐Ambrosi, J. (2012) · Nutrition Research Reviews · doi:10.1017/s0954422412000145 · Cited by 66
Animal models of NAFLD from the pathologist's point of view
Denk, H., Abuja, P. M., & Zatloukal, K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.024 · Cited by 65
Mechanisms of Disease Progression in NASH
Bohinc, B. N., & Diehl, A. M. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.05.002 · Cited by 64
Self-citationRegulators of Cholangiocyte Proliferation
Hall, C. M., Sato, K., Wu, N., Zhou, T., Kyritsi, K., Meng, F., Glaser, S. S., & Alpini, G. D. (2016) · Gene Expression · doi:10.3727/105221616x692568 · Cited by 61
The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time
Effendi, W. I., & Nagano, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010171 · Cited by 59
Moayedfard, Z., Sani, F., Alizadeh, A. A., Lankarani, K. B., Zarei, M., & Azarpira, N. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02929-6 · Cited by 60
Evolution of hepatic fibrosis research
Kawada, N. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00776.x · Cited by 58
The Space of Disse: The Liver Hub in Health and Disease
Sanz-García, C., Fernández-Iglesias, A., Gracia-Sancho, J., Arráez-Aybar, L. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Livers · doi:10.3390/livers1010002 · Cited by 57
Osteopontin as a Biomarker in Chronic Kidney Disease
Sinha, S. K., Mellody, M., Carpio, M. B., Damoiseaux, R. D., & Nicholas, S. B. (2023) · Biomedicines · doi:10.3390/biomedicines11051356 · Cited by 67
Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis
Coombes, J. D., Choi, S. S., Swiderska‐Syn, M., Manka, P. P., Reid, D. T., Palma, E., Briones-Orta, M. A., Xie, G., Younis, R. L., Kitamura, N., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.028 · Cited by 59
Self-citationLevitsky, J., Baker, T., Jie, C., Ahya, S. N., Levin, M. L., Friedewald, J. J., Al-Saden, P. C., Salomon, D. R., & Abecassis, M. M. (2014) · Hepatology · doi:10.1002/hep.27346 · Cited by 55
Ibrahim, S. H., Gores, G. J., Hirsova, P., Kirby, M., Miles, L., Jaeschke, A., & Kohli, R. (2013) · Liver International · doi:10.1111/liv.12353 · Cited by 54
Moon, H., Cho, K., Shin, S., Kim, D. Y., Han, K., & Ro, S. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030581 · Cited by 56
Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
Lee, H. J., Yeon, J. E., Suh, S. J., Lee, S.-J., Yoon, E. L., Kang, K., Yoo, Y. J., Kim, J. H., Seo, Y. S., Yim, H. J., et al. (2014) · Gut and Liver · doi:10.5009/gnl.2014.8.2.177 · Cited by 53
Targeting Pericyte Differentiation as a Strategy to Modulate Kidney Fibrosis in Diabetic Nephropathy
Humphreys, B. D. (2012) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.07.009 · Cited by 53
Okazaki, I., Noro, T., Tsutsui, N., Yamanouchi, E., Kuroda, H., Nakano, M., Yokomori, H., & Inagaki, Y. (2014) · Cancers · doi:10.3390/cancers6031220 · Cited by 55
The hedgehog pathway in nonalcoholic fatty liver disease
Machado, M. V., & Diehl, A. M. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1448752 · Cited by 52
Self-citationIntracellular Osteopontin Inhibits Toll-like Receptor Signaling and Impedes Liver Carcinogenesis
Fan, X., He, C., Jing, W., Zhou, X., Chen, R., Cao, L., Zhu, M., Jia, R., Wang, H., Guo, Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0615 · Cited by 51
Zonation in NASH – A key paradigm for understanding pathophysiology and clinical outcomes
Steinman, J. B., Salomao, M. A., & Pajvani, U. B. (2021) · Liver International · doi:10.1111/liv.15025 · Cited by 49
Osteopontin is an important mediator of alcoholic liver diseaseviahepatic stellate cell activation
Seth, D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.13088 · Cited by 51
The Hedgehog Signaling Pathway Emerges as a Pathogenic Target
Smelkinson, M. G. (2017) · Journal of Developmental Biology · doi:10.3390/jdb5040014 · Cited by 49
GLP‐1 receptor agonists: effects on the progression of non‐alcoholic fatty liver disease
Liu, J., Wang, G., Jia, Y., & Xu, Y. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2580 · Cited by 48
Osteopontin deficiency aggravates hepatic injury induced by ischemia–reperfusion in mice
Patouraux, S., Rousseau, D., Rubio, A., Bonnafous, S., Lavallard, V., Lauron, J., Saint-Paul, M. C., Bailly‐Maitre, B., Tran, A., Crénesse, D., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.174 · Cited by 48
Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition
Chen, Y., Ou, Y., Dong, J., Yang, G., Zeng, Z., Liu, Y., Liu, B., Li, W., He, X., & Lan, T. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.11.035 · Cited by 48
Self-citationThe critical role of osteopontin (OPN) in fibrotic diseases
Tang, Z., Xia, Z., Wang, X., & Liu, Y. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.08.007 · Cited by 47
Metadata
- Authors
- Syn, W.-K., Choi, S. S., Liaskou, E., Karaca, G. F., Agboola, K. M., Oo, Y. H., Mi, Z., Pereira, T. A., Zdanowicz, M., Malladi, P., Chen, Y., Moylan, C., Jung, Y., Bhattacharya, S. D., Teaberry, V., Omenetti, A., Abdelmalek, M. F., Guy, C. D., Adams, D. H., Kuo, P. C., Michelotti, G. A., Whitington, P. F., & Diehl, A. M.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- University of Birmingham (GB)
- Northwestern University (US)
- Corresponding author
- Syn, Wing-Kin
- Diehl, Anna Mae
- ORCID
- Venue
- Hepatology
- Published
- 2011-01
- Volume
- 53
- Issue
- 1
- Pages
- 106-115
- ISSN
- 0270-9139 (ISSN-L)
- PMC
- PMC3025083
- OpenAlex
- W2039567228
- Cited by
- 275
- References
- 40
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 18 · 2023: 18 · 2022: 19 · 2021: 19 · 2020: 13 · 2019: 14 · 2018: 18 · 2017: 16 · 2016: 17 · 2015: 23 · 2014: 25 · 2013: 15 · 2012: 23
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Wellcome Trust
- Alberta Innovates - Health Solutions
- National Institutes of Health (1k08dk080980-01a1, 1r01aa014257-01a2)
- National Institute on Alcohol Abuse and Alcoholism (R01 AA014257, 5R01AA14257-5)
- National Institute of General Medical Sciences (R01GM065113)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK077794, K08 DK-080980, R01DK053792)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- osteopontin, Hedgehog signaling, nonalcoholic steatohepatitis, liver fibrosis, hepatic stellate cells, Patched1, methionine-choline-deficient diet, cholangiocytes, extracellular matrix, fibrosis progression, RNA aptamers, cyclopamine, sag
- MeSH terms
- Animals, Cell Line, Choline Deficiency, Diet, Fatty Liver, Humans, Liver Cirrhosis, Methionine, Mice, Inbred C57BL, Veratrum Alkaloids, Up-Regulation, Mice, Osteopontin, Hedgehog Proteins, Hepatic Stellate Cells, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
